| ²é¿´: 433 | »Ø¸´: 0 | ||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | ||
[×ÊÔ´]
Target Validation in Drug Discovery
|
||
|
Target Validation in Drug Discovery Publisher: Academic Press | ISBN: 0123693934 | edition 2006 | PDF | 296 pages | 4,57 mb This work presents a comprehensive contemporary framework for approaching target validation in drug discovery. It begins with a detailed description of new enabling technologies, including aptamers, RNA interference, functional genomics, and proteomics. The next section looks at biologic drug development with in-depth discussion of lessons learned from such well-known cases as Erbitux, Herceptin, and Avastin. Additional targets known as "second generation" drugs, which can be identified when disease pathways are validated by biologics, present new possible small molecule therapeutics and serve as the focus of the final section of the book. http://depositfiles.com/en/files/9zc4tp3wh |
» ²ÂÄãϲ»¶
²ÄÁϵ÷¼Á
ÒѾÓÐ9È˻ظ´
311£¨085601£©Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
307·ÖÇóµ÷¼Á
ÒѾÓÐ6È˻ظ´
085601Ó¢¶þÊý¶þÇóµ÷¼Á ×Ü·Ö325
ÒѾÓÐ3È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
ÉúÒ½¹¤0831µ÷¼ÁÇóÍÆ¼ö
ÒѾÓÐ6È˻ظ´
ÉúÎïѧ296Çóµ÷¼Á
ÒѾÓÐ12È˻ظ´
Ò»Ö¾Ô¸ÎäÀí²ÄÁϹ¤³Ì302µ÷¼Á»·»¯»ò»¯¹¤
ÒѾÓÐ4È˻ظ´
286·Öµ÷¼Á
ÒѾÓÐ12È˻ظ´
¸´ÊÔµ÷¼Á
ÒѾÓÐ3È˻ظ´














»Ø¸´´ËÂ¥